Lab Anim Res.  2017 Jun;33(2):132-139. 10.5625/lar.2017.33.2.132.

Comparison of humoral and cell-mediated immunity in three different C57BL/6N mouse substrains

Affiliations
  • 1Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang 50463, Korea. dyhwang@pusan.ac.kr
  • 2College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.
  • 3College of Pharmacy, Pusan National University, Busan 46241, Korea.
  • 4Exercise Biochemistry Laboratory, Korea National Sport University, Seoul 05541, Korea.
  • 5Department of Microbiology and Immunology, INJE University College of Medicine, Busan 47392, Korea. kali71@hanmail.net

Abstract

Adaptive immunity is a type of immune response mediated by T and B cells, and is important response for immune response amplification and memory. In this study, the adaptive immunologic properties of C57BL/6NKorl substrain were compared with those of two other C57BL/6N substrains. There were no significant differences between the C57BL/6NKorl and the two other C57BL/6N substrains in the histological structures of the thymus and spleen, which are immunologic organs containing T cell and B cells. In addition, flow cytometric analysis did not reveal any significant differences in the distribution of T and B cell populations of the three substrains. To evaluate cell-mediated immunity of T cells in the three different substrains, we treated isolated T cells from spleen with Con A. The T cells of C57BL/6NKorl showed Con A-dependent proliferation of T cells at lower cell number than those in T cells from the other two C57BL/6N substrains. B cell-mediated humoral immune responses were not significant different among the three substrains. Thus, the results of this study provide evidence that C57BL/6NKorl mice are similar to those two other C57BL/6N substrains in humoral immunity, but C57BL/6NKorl has stronger response in cell mediated immunity.

Keyword

C57BL/6N; C57BL/6NKorl; T cell; B cell; cell-mediated immunity; humoral immunity

MeSH Terms

Adaptive Immunity
Animals
B-Lymphocytes
Cell Count
Immunity, Cellular*
Immunity, Humoral
Memory
Mice*
Spleen
T-Lymphocytes
Thymus Gland

Figure

  • Figure 1 Histological difference of thymus structure among C57BL/6NKorl, C57BL/6NA, and C57BL/6NB mice. Thymus tissues were stained with H&E. Upper line displayed at 100× magnification. Bottom line was viewed at 40× magnification. Arrow, cortex; arrow head, medulla.

  • Figure 2 Histological difference of spleen structure among C57BL/6NKorl, C57BL/6NA, and C57BL/6NB mice. Spleen tissues were stained with H&E. Upper line displayed at 100× magnification. Bottom line was viewed at 40× magnification. Arrow, Red pulp; arrow head, white pulp and lymphoid follicle.

  • Figure 3 The relative level of lymphocyte population in C57BL/6NKorl, C57BL/6NA, and C57BL/6NB mice. Histogram plots from flow cytometry represent the populations of T cells (left panel) and B cells (right panel) from spleen. Results are representative of 3 independent experiments.

  • Figure 4 Determination of cell-mediated immunotoxicity. After treatment with different Con A doses, the growth of cells was measured by using WST-1 assays. The data are presented as means±SD of three experiments. (A) and (B) panels was display responses of splenic T cells from C57BL/6NA and C57BL/6NB substrain, respectively. (C) The data presented the response of splenic T cells from C57BL/6NKorl substrain. *P<0.05 vs. med group. Med, media-treated group; Con A, concanavalin A.

  • Figure 5 Determination of humoral immunotoxicity. After treatment with different LPS doses, the growth of cells was measured by using WST-1 assays. The data are presented as the means±SD of the experiments. (A) and (B) panels display response of splenic B cell from two different source C57BL/6N substrain. (C) The data presented response of splenic B cells from C57BL/6NKorl substrain. *P<0.05 vs. med group. Med, media-treated group; LPS, lipopolysaccharide.


Reference

1. Wade CM, Daly MJ. Genetic variation in laboratory mice. Nat Genet. 2005; 37(11):1175–1180. PMID: 16254563.
Article
2. Barros SF, Friedlanskaia I, Petricevich VL, Kipnis TL. Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom. Mediators Inflamm. 1998; 7(5):339–346. PMID: 9883969.
3. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl). 1997; 132(2):107–124. PMID: 9266608.
Article
4. Harris RB, Mitchell TD, Yan X, Simpson JS, Redmann SM Jr. Metabolic responses to leptin in obese db/db mice are strain dependent. Am J Physiol Regul Integr Comp Physiol. 2001; 281(1):R115–R132. PMID: 11404285.
Article
5. Kile BT, Mason-Garrison CL, Justice MJ. Sex and strain-related differences in the peripheral blood cell values of inbred mouse strains. Mamm Genome. 2003; 14(1):81–85. PMID: 12532271.
Article
6. Madiehe AM, Hebert S, Mitchell TD, Harris RB. Strain-dependent stimulation of growth in leptin-treated obese db/db mice. Endocrinology. 2002; 143(10):3875–3883. PMID: 12239099.
7. Nishina PM, Wang J, Toyofuku W, Kuypers FA, Ishida BY, Paigen B. Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids. 1993; 28(7):599–605. PMID: 8355588.
Article
8. Opsahl ML, McClenaghan M, Springbett A, Reid S, Lathe R, Colman A, Whitelaw CB. Multiple effects of genetic background on variegated transgene expression in mice. Genetics. 2002; 160(3):1107–1112. PMID: 11901126.
Article
9. Rossmeisl M, Rim JS, Koza RA, Kozak LP. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity. Diabetes. 2003; 52(8):1958–1966. PMID: 12882911.
Article
10. Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol. 2012; 49(1):32–43. PMID: 22135019.
11. van Bogaert MJ, Groenink L, Oosting RS, Westphal KG, van der Gugten J, Olivier B. Mouse strain differences in autonomic responses to stress. Genes Brain Behav. 2006; 5(2):139–149. PMID: 16507005.
Article
12. Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis. 2004; 25(9):1771–1778. PMID: 15105299.
Article
13. Dux A, Mühlbock O, Bailey DW. Genetic analyses of differences in incidence of mammary tumors and reticulum cell neoplasms with the use of recombinant inbred lines of mice. J Natl Cancer Inst. 1978; 61(4):1125–1129. PMID: 212568.
14. Festing MF. Properties of inbred strains and outbred stocks, with special reference to toxicity testing. J Toxicol Environ Health. 1979; 5(1):53–68. PMID: 423306.
Article
15. Zurita E, Chagoyen M, Cantero M, Alonso R, González-Neira A, López-Jiménez A, López-Moreno JA, Landel CP, Benítez J, Pazos F, Montoliu L. Genetic polymorphisms among C57BL/6 mouse inbred strains. Transgenic Res. 2011; 20(3):481–489. PMID: 20506040.
Article
16. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J Natl Cancer Inst. 1980; 65(5):929–935. PMID: 6933263.
17. Boehm T. Design principles of adaptive immune systems. Nat Rev Immunol. 2011; 11(5):307–317. PMID: 21475308.
Article
18. Chen J, Flurkey K, Harrison DE. A reduced peripheral blood CD4(+) lymphocyte proportion is a consistent ageing phenotype. Mech Ageing Dev. 2002; 123(2-3):145–153. PMID: 11718808.
Article
19. Chen J, Harrison DE. Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood. Blood. 2002; 99(2):561–566. PMID: 11781239.
Article
20. Glineur S, Antoine-Moussiaux N, Michaux C, Desmecht D. Immune depression of the SJL/J mouse, a radioresistant and immunologically atypical inbred strain. Immunobiology. 2011; 216(1-2):213–217. PMID: 20965099.
21. Mayer A, Lilly F, Duran-Reynals ML. Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma. Proc Natl Acad Sci U S A. 1980; 77(5):2960–2963. PMID: 6930679.
Article
22. McVicar DW, Winkler-Pickett R, Taylor LS, Makrigiannis A, Bennett M, Anderson SK, Ortaldo JR. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J Immunol. 2002; 169(4):1721–1728. PMID: 12165492.
Article
23. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000; 164(12):6166–6173. PMID: 10843666.
Article
24. Green MC, Grueneberg H, Hertwig P, Heston WE, Lyon MF, Medvedev NN, Snell GD, Staats J. A revision of the standardized genetic nomenclature for mice. J Hered. 1963; 54:159–162. PMID: 14057864.
25. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE. Mouse Genome Database Group. The mouse genome database (MGD): new features facilitating a model system. Nucleic Acids Res. 2007; 35(Database issue):D630–D637. PMID: 17135206.
Article
26. Mouse genetics: concepts and applications. New York: Oxford University Press;1995. p. 3–31.
Full Text Links
  • LAR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr